193 related articles for article (PubMed ID: 15131128)
1. Structure and function of recombinant cobra venom factor.
Kock MA; Hew BE; Bammert H; Fritzinger DC; Vogel CW
J Biol Chem; 2004 Jul; 279(29):30836-43. PubMed ID: 15131128
[TBL] [Abstract][Full Text] [Related]
2. Recombinant cobra venom factor.
Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
[TBL] [Abstract][Full Text] [Related]
3. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
4. Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stability.
Hew BE; Pangburn MK; Vogel CW; Fritzinger DC
Toxicon; 2020 Sep; 184():68-77. PubMed ID: 32526239
[TBL] [Abstract][Full Text] [Related]
5. Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteins.
Hew BE; Fritzinger DC; Pangburn MK; Vogel CW
Toxicon; 2019 Sep; 167():106-116. PubMed ID: 31207349
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.
Krishnan V; Ponnuraj K; Xu Y; Macon K; Volanakis JE; Narayana SV
Structure; 2009 Apr; 17(4):611-9. PubMed ID: 19368894
[TBL] [Abstract][Full Text] [Related]
8. Methionine modification impairs the C5-cleavage function of cobra venom factor-dependent C3/C5 convertase.
Fu Q; McPhie P; Gowda DC
Biochem Mol Biol Int; 1998 Jun; 45(1):133-44. PubMed ID: 9635137
[TBL] [Abstract][Full Text] [Related]
9. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
Vogel CW; Fritzinger DC
Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructure of cobra venom factor-dependent C3/C5 convertase and its zymogen, factor B of human complement.
Smith CA; Vogel CW; Müller-Eberhard HJ
J Biol Chem; 1982 Sep; 257(17):9879-82. PubMed ID: 6921201
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning and derived primary structure of cobra venom factor.
Fritzinger DC; Bredehorst R; Vogel CW
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12775-9. PubMed ID: 7809120
[TBL] [Abstract][Full Text] [Related]
12. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
Janssen BJ; Gomes L; Koning RI; Svergun DI; Koster AJ; Fritzinger DC; Vogel CW; Gros P
EMBO J; 2009 Aug; 28(16):2469-78. PubMed ID: 19574954
[TBL] [Abstract][Full Text] [Related]
13. A cobra venom factor (CVF)-induced C3 convertase activity in the hemolymph of Galleria mellonella.
Phipps D; Menger M; Chadwick JS; Aston WP
Dev Comp Immunol; 1987; 11(1):37-46. PubMed ID: 3647909
[TBL] [Abstract][Full Text] [Related]
14. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
Rehana S; Manjunatha Kini R
Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
[TBL] [Abstract][Full Text] [Related]
15. Substrate recognition by complement convertases revealed in the C5-cobra venom factor complex.
Laursen NS; Andersen KR; Braren I; Spillner E; Sottrup-Jensen L; Andersen GR
EMBO J; 2011 Feb; 30(3):606-16. PubMed ID: 21217642
[TBL] [Abstract][Full Text] [Related]
16. Functional role of the noncatalytic subunit of complement C5 convertase.
Rawal N; Pangburn MK
J Immunol; 2000 Feb; 164(3):1379-85. PubMed ID: 10640753
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage.
von Zabern I; Hinsch B; Przyklenk H; Schmidt G; Vogt W
Immunobiology; 1980 Dec; 157(4-5):499-514. PubMed ID: 6905795
[TBL] [Abstract][Full Text] [Related]
18. Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury.
Gorsuch WB; Guikema BJ; Fritzinger DC; Vogel CW; Stahl GL
Mol Immunol; 2009 Dec; 47(2-3):506-10. PubMed ID: 19747734
[TBL] [Abstract][Full Text] [Related]
19. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
Usami M; Ohno Y
J Pharmacol Toxicol Methods; 2005; 52(2):260-3. PubMed ID: 16125624
[TBL] [Abstract][Full Text] [Related]
20. Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis.
Sharma S; Jabeen T; Singh RK; Bredhorst R; Vogel CW; Betzel C; Singh TP
Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):596-8. PubMed ID: 11264593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
